Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 40
Filter
Add more filters

Country/Region as subject
Publication year range
1.
J Am Anim Hosp Assoc ; 60(2): 87-91, 2024 Mar 01.
Article in English | MEDLINE | ID: mdl-38394692

ABSTRACT

A 4 yr old castrated male greyhound presented with a history of chronic (>3 wk) intermittent diarrhea. Initial fecal analysis identified infection with Ancylostoma caninum. Despite treatment with routine anthelmintics, the dog remained persistently A caninum positive for several months. A novel fecal gastrointestinal real-time polymerase chain reaction (qPCR) parasite panel detected A caninum and the genetic benzimidazole (BZ) F167Y resistance marker in multiple samplings over 48 hr. This finding, together with the dog's clinical signs (diarrhea) and lack of response to routine anthelmintics, prompted treatment with cyclooctadepsipeptide emodepside, a drug currently not registered for dogs in the United States. The dog's clinical signs resolved and post-treatment fecal qPCR testing was negative. However, 5 mo later, retesting with fecal qPCR detected A caninum and concurrent BZ resistance marker, as well as Giardia. A presumptive diagnosis of re-infection was made and the emodepside treatment was continued. The dog again reverted to undetected (A caninum and the 167 resistance marker) on reassessment fecal qPCR. This case report describes the use of a novel fecal qPCR panel for gastrointestinal parasites, persistent hookworm and BZ F167Y resistance marker detection in a dog, and highlights the importance of a stepwise approach to clinical management, treatment, and retesting.


Subject(s)
Anthelmintics , Dog Diseases , Dogs , Male , Animals , United States , Ancylostoma/genetics , Ancylostomatoidea/genetics , Dog Diseases/diagnosis , Dog Diseases/drug therapy , Dog Diseases/parasitology , Anthelmintics/pharmacology , Anthelmintics/therapeutic use , Benzimidazoles/pharmacology , Benzimidazoles/therapeutic use , Feces/parasitology , Polymerase Chain Reaction/veterinary , Diarrhea/drug therapy , Diarrhea/veterinary
2.
Emerg Infect Dis ; 29(11): 2298-2306, 2023 11.
Article in English | MEDLINE | ID: mdl-37877570

ABSTRACT

Salmonella infection causes epidemic death in wild songbirds, with potential to spread to humans. In February 2021, public health officials in Oregon and Washington, USA, isolated a strain of Salmonella enterica serovar Typhimurium from humans and a wild songbird. Investigation by public health partners ultimately identified 30 illnesses in 12 states linked to an epidemic of Salmonella Typhimurium in songbirds. We report a multistate outbreak of human salmonellosis associated with songbirds, resulting from direct handling of sick and dead birds or indirect contact with contaminated birdfeeders. Companion animals might have contributed to the spread of Salmonella between songbirds and patients; the outbreak strain was detected in 1 ill dog, and a cat became ill after contact with a wild bird. This outbreak highlights a One Health issue where actions like regular cleaning of birdfeeders might reduce the health risk to wildlife, companion animals, and humans.


Subject(s)
Salmonella Food Poisoning , Salmonella Infections, Animal , Songbirds , Humans , Animals , United States/epidemiology , Dogs , Salmonella typhimurium , Salmonella Infections, Animal/epidemiology , Salmonella Food Poisoning/epidemiology , Animals, Wild , Disease Outbreaks , Oregon
3.
Int J Cancer ; 152(2): 137-150, 2023 01 15.
Article in English | MEDLINE | ID: mdl-35904861

ABSTRACT

Declines in cervical intraepithelial neoplasia grades 2 to 3 and adenocarcinoma in situ (CIN2+) observed among young women suggest impact from human papillomavirus (HPV) vaccination. To further evaluate vaccine impact including cross-protection and type replacement, we described high-risk (HR)-HPV type-specific cervical precancer incidence rates among women aged 20 to 39 years, 2008 to 2016. We analyzed cross-sectional population-based data on 18 344 cases of CIN2+ from a 5-site surveillance system. Diagnostic specimens were tested for individual HPV types, including 14 HR-HPV types (HPV16/18/31/33/35/39/45/51/52/56/58/59/66/68). We estimated age-specific annual HR-HPV type-specific CIN2+ incidence per 100 000 screened women for individual types, vaccine HR-HPV types (HPV16/18) and nonvaccine HR-HPV types (non-HPV16/18). We evaluated trends using average annual percent changes (AAPC) and 95% confidence intervals (CI), and estimated total declines by comparing 2015-2016 to 2008-2009 using incidence rate ratios. Among 20-24-year-olds, HPV16/18-CIN2+ declined from 2008 through 2016 (AAPC: -21.3%, 95% CI: -28.1%, -13.8%), whereas no trend was observed for non-HPV16/18-CIN2+ (AAPC: -1.8%, 95% CI: -8.1%, 4.9%). After 2010, CIN2+ among 20-24-year-olds was more often caused by nonvaccine vs vaccine HR-HPV types. No significant declining trends were observed in older age groups. In 2015-2016 compared with 2008-2009, HPV16-CIN2+ declined 78%, HPV18-CIN2+ 72% and HPV31-CIN2+ 51% among 20-24-year-olds; no increases were observed in type-specific CIN2+ incidence. Among 25-29-year-olds, HPV16-CIN2+ declined 18%; CIN2+ attributed to seven nonvaccine types increased significantly. No significant declines were observed in older groups. Significant declines in HPV16/18-CIN2+ in 20-24-year-olds and HPV16-CIN2+ in 25-29-year-olds corroborate impact of HPV vaccination. A declining trend in HPV31-CIN2+ is consistent with cross-protection from vaccination.


Subject(s)
Papillomavirus Vaccines , Uterine Cervical Dysplasia , Uterine Cervical Neoplasms , Humans , Female , United States/epidemiology , Aged , Uterine Cervical Neoplasms/pathology , Cross-Sectional Studies , Papillomavirus Vaccines/therapeutic use , Human papillomavirus 16 , Human papillomavirus 31
4.
Clin Infect Dis ; 73(7): 1133-1141, 2021 10 05.
Article in English | MEDLINE | ID: mdl-33772538

ABSTRACT

BACKGROUND: Cryptococcosis due to Cryptococcus neoformans and Cryptococcus gattii varies with geographic region, populations affected, disease manifestations, and severity of infection, which impact treatment. METHODS: We developed a retrospective cohort of patients diagnosed with culture-proven cryptococcosis during 1995-2013 from 5 centers in North America and Australia. We compared underlying diseases, clinical manifestations, treatment, and outcomes in patients with C. gattii or C. neoformans infection. RESULTS: A total of 709 patients (452 C. neoformans; 257 C. gattii) were identified. Mean age was 50.2 years; 61.4% were male; and 52.3% were white. Time to diagnosis was prolonged in C. gattii patients compared with C. neoformans (mean, 52.2 vs 36.0 days; P < .003), and there was a higher proportion of C. gattii patients without underlying disease (40.5% vs 10.2%; P < .0001). Overall, 59% had central nervous system (CNS) infection, with lung (42.5%) and blood (24.5%) being common sites. Pulmonary infection was more common in patients with C. gattii than in those with C. neoformans (60.7% vs 32.1%; P < .0001). CNS or blood infections were more common in C. neoformans-infected patients (P ≤ .0001 for both). Treatment of CNS disease with induction therapy of amphotericin B and flucytosine occurred in 76.4% of patients. Crude 12-month mortality was higher in patients with C. neoformans (28.4% vs 20.2%; odds ratio, 1.56 [95% confidence interval, 1.08-2.26]). CONCLUSIONS: This study emphasizes differences in species-specific epidemiology and outcomes of patients with cryptococcosis, including underlying diseases, site of infection, and mortality. Species identification in patients with cryptococcosis is necessary to discern epidemiologic patterns, guide treatment regimens, and predict clinical progression and outcomes.


Subject(s)
Cryptococcosis , Cryptococcus gattii , Cryptococcus neoformans , Cohort Studies , Cryptococcosis/drug therapy , Cryptococcosis/epidemiology , Humans , Male , Middle Aged , Retrospective Studies
5.
J Infect Dis ; 221(11): 1864-1874, 2020 05 11.
Article in English | MEDLINE | ID: mdl-31957785

ABSTRACT

BACKGROUND: Most information on mucosal and systemic immune response to norovirus infection is derived from human challenge studies, birth cohort studies, or vaccine trials in healthy adults. However, few data are available on immune responses to norovirus in the elderly. METHODS: To study the mucosal and systemic immune response against norovirus, 43 long-term care facilities were enrolled prospectively in 2010-2014. Baseline saliva samples from 17 facilities, cases and controls up to day 84 from 10 outbreaks, as well as acute and convalescent sera were collected. RESULTS: Norovirus-specific immunoglobulin A (IgA) levels in baseline saliva samples were low and increased in both symptomatic patients and asymptomatic shedders at day 5 after onset during outbreaks. Receiver operating characteristics analysis correctly assigned prior norovirus infection in 23 (92%) of 25 participants. Cases and asymptomatic shedders showed seroconversion for IgG (80%), IgA (78%), and blockade antibodies (87%). Salivary IgA levels strongly correlated with increased convalescent serum IgA titers and blockade antibodies. CONCLUSIONS: Salivary IgA levels strongly correlated with serum IgA titers and blockade antibodies and remained elevated 3 months after a norovirus outbreak. A single salivary sample collected on day 14 could be used to identify recent infection in a suspected outbreak or to monitor population salivary IgA.


Subject(s)
Caliciviridae Infections/immunology , Immunoglobulin A/analysis , Saliva/virology , Aged , Caliciviridae Infections/diagnosis , Case-Control Studies , Female , Humans , Immunoglobulin A/blood , Male , Middle Aged , Norovirus , Virus Shedding
6.
Emerg Infect Dis ; 24(8): 1444-1452, 2018 07.
Article in English | MEDLINE | ID: mdl-30014837

ABSTRACT

Although coccidioidomycosis in Arizona and California has been well-characterized, much remains unknown about its epidemiology in states where it is not highly endemic. We conducted enhanced surveillance in 14 such states in 2016 by identifying cases according to the Council of State and Territorial Epidemiologists case definition and interviewing patients about their demographic characteristics, clinical features, and exposures. Among 186 patients, median time from seeking healthcare to diagnosis was 38 days (range 1-1,654 days); 70% had another condition diagnosed before coccidioidomycosis testing occurred (of whom 83% were prescribed antibacterial medications); 43% were hospitalized; and 29% had culture-positive coccidioidomycosis. Most (83%) patients from nonendemic states had traveled to a coccidioidomycosis-endemic area. Coccidioidomycosis can cause severe disease in residents of non-highly endemic states, a finding consistent with previous studies in Arizona, and less severe cases likely go undiagnosed or unreported. Improved coccidioidomycosis awareness in non-highly endemic areas is needed.


Subject(s)
Coccidioidomycosis/epidemiology , Adolescent , Adult , Age Factors , Aged , Child , Coccidioidomycosis/ethnology , Communicable Diseases, Emerging/epidemiology , Ethnicity , Female , Humans , Male , Middle Aged , Patient Acceptance of Health Care/statistics & numerical data , Population Surveillance/methods , Travel , United States/epidemiology , Young Adult
8.
Emerg Infect Dis ; 22(1): 79-82, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26689610

ABSTRACT

Brucella suis infection was diagnosed in a man from Tonga, Polynesia, who had butchered swine in Oregon, USA. Although the US commercial swine herd is designated brucellosis-free, exposure history suggested infection from commercial pigs. We used whole-genome sequencing to determine that the man was infected in Tonga, averting a field investigation.


Subject(s)
Brucella suis/genetics , Brucellosis/microbiology , Animals , Brucellosis/veterinary , Humans , Male , Oregon , Swine/microbiology , Tonga
9.
MMWR Morb Mortal Wkly Rep ; 64(52): 1398-402, 2016 Jan 08.
Article in English | MEDLINE | ID: mdl-26741355

ABSTRACT

In 2013, public health officials in Multnomah County, Oregon, started an investigation of a tuberculosis (TB) outbreak among elephants and humans at a local zoo. The investigation ultimately identified three bull elephants with active TB and 118 human contacts of the elephants. Ninety-six (81%) contacts were evaluated, and seven close contacts were found to have latent TB infection. The three bulls were isolated and treated (elephants with TB typically are not euthanized) to prevent infection of other animals and humans, and persons with latent infection were offered treatment. Improved TB screening methods for elephants are needed to prevent exposure of human contacts.


Subject(s)
Animals, Zoo/microbiology , Contact Tracing , Disease Outbreaks , Mycobacterium tuberculosis/isolation & purification , Occupational Diseases/diagnosis , Tuberculosis/diagnosis , Tuberculosis/veterinary , Animals , Disease Outbreaks/prevention & control , Disease Outbreaks/veterinary , Elephants , Humans , Latent Tuberculosis/diagnosis , Latent Tuberculosis/epidemiology , Latent Tuberculosis/prevention & control , Occupational Diseases/epidemiology , Oregon/epidemiology , Tuberculin Test/veterinary , Tuberculosis/epidemiology , Tuberculosis/prevention & control
10.
MMWR Morb Mortal Wkly Rep ; 64(14): 399, 2015 Apr 17.
Article in English | MEDLINE | ID: mdl-25879900

ABSTRACT

On January 8, 2014, the Ohio Department of Health notified the Oregon Public Health Division (OPHD) of campylobacteriosis in two Ohio residents recently returned from Oregon. The travelers reported consuming chicken liver pâté* at an Oregon restaurant. On January 10, OPHD received additional reports of campylobacteriosis in two persons who had consumed chicken liver pâté at another Oregon restaurant. Campylobacter jejuni was isolated in cultures of fecal specimens from three patients. OPHD investigated to determine the sources of the illnesses and to institute preventive measures.


Subject(s)
Campylobacter Infections/epidemiology , Campylobacter jejuni/isolation & purification , Disease Outbreaks , Food Microbiology , Foodborne Diseases/epidemiology , Meat/microbiology , Animals , Campylobacter Infections/microbiology , Chickens , Cooking , Feces/microbiology , Foodborne Diseases/microbiology , Humans , Liver , Ohio/epidemiology , Oregon/epidemiology , Restaurants
11.
MMWR Morb Mortal Wkly Rep ; 64(33): 918-9, 2015 Aug 28.
Article in English | MEDLINE | ID: mdl-26313475

ABSTRACT

Since April 1, 2015, a total of 11 cases of human plague have been reported in residents of six states: Arizona (two), California (one), Colorado (four), Georgia (one), New Mexico (two), and Oregon (one). The two cases in Georgia and California residents have been linked to exposures at or near Yosemite National Park in the southern Sierra Nevada Mountains of California. Nine of the 11 patients were male; median age was 52 years (range = 14-79 years). Three patients aged 16, 52, and 79 years died.


Subject(s)
Plague/epidemiology , Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Plague/diagnosis , United States/epidemiology , Young Adult
12.
MMWR Morb Mortal Wkly Rep ; 64(3): 58-60, 2015 Jan 30.
Article in English | MEDLINE | ID: mdl-25632952

ABSTRACT

Tickborne relapsing fever (TBRF) is a zoonosis caused by spirochetes of the genus Borrelia and transmitted to humans by ticks of the genus Ornithodoros. TBRF is endemic in the western United States, predominately in mountainous regions. Clinical illness is characterized by recurrent bouts of fever, headache, and malaise. Although TBRF is usually a mild illness, severe sequelae and death can occur. This report summarizes the epidemiology of 504 TBRF cases reported from 12 western states during 1990-2011. Cases occurred most commonly among males and among persons aged 10‒14 and 40‒44 years. Most reported infections occurred among nonresident visitors to areas where TBRF is endemic. Clinicians and public health practitioners need to be familiar with current epidemiology and features of TBRF to adequately diagnose and treat patients and recognize that any TBRF case might indicate an ongoing source of potential exposure that needs to be investigated and eliminated.


Subject(s)
Borrelia/isolation & purification , Endemic Diseases , Ornithodoros , Relapsing Fever/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Animals , Child , Child, Preschool , Female , Humans , Infant , Male , Middle Aged , Relapsing Fever/diagnosis , United States/epidemiology , Young Adult
13.
Emerg Infect Dis ; 20(4): 603-11, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24655581

ABSTRACT

To evaluate trends in and risk factors for acquisition of antimicrobial-drug resistant nontyphoidal Salmonella infections, we searched Oregon surveillance data for 2004-2009 for all culture-confirmed cases of salmonellosis. We defined clinically important resistance (CIR) as decreased susceptibility to ampicillin, ceftriaxone, ciprofloxacin, gentamicin, or trimethoprim/sulfamethoxazole. Of 2,153 cases, 2,127 (99%) nontyphoidal Salmonella isolates were obtained from a specific source (e.g., feces, urine, blood, or other normally sterile tissue) and had been tested for drug susceptibility. Among these, 347 (16%) isolates had CIR. The odds of acquiring CIR infection significantly increased each year. Hospitalization was more likely for patients with than without CIR infections. Among patients with isolates that had been tested, we analyzed data from 1,813 (84%) who were interviewed. Travel to eastern or Southeast Asia was associated with increased CIR. Isolates associated with outbreaks were less likely to have CIR. Future surveillance activities should evaluate resistance with respect to international travel.


Subject(s)
Anti-Infective Agents/therapeutic use , Salmonella Food Poisoning/epidemiology , Salmonella Infections/epidemiology , Salmonella/isolation & purification , Adolescent , Adult , Child , Drug Resistance, Multiple, Bacterial , Female , Hospitalization , Humans , Male , Microbial Sensitivity Tests/methods , Middle Aged , Risk Factors , Salmonella Food Poisoning/microbiology , Salmonella Infections/microbiology , Travel , Young Adult
14.
BMC Microbiol ; 14: 323, 2014 Dec 21.
Article in English | MEDLINE | ID: mdl-25528464

ABSTRACT

BACKGROUND: In Oregon, human and animal infections by C. gattii were first identified in 2004. Cryptococcus gattii is considered to be an emerging non-zoonotic infection affecting animals and humans in Oregon. We report a longitudinal environmental isolation of C. gattii after an Oregon dog was diagnosed with the disease in 2009. RESULTS: Cryptococcus gattii was isolated twice from the same location with a span of one year between isolation dates. Cryptococcus gattii molecular types VGIIa and VGI were isolated in 2010 from soil and tree bark near the home of a 9-month-old dog which three months previously had an infection caused by C. gattii genotype VGIIa. The environment featured heavy growth of Douglas Fir trees. In 2011, a second set of soil and tree bark samples was collected in the same area and C. gattii VGIIa was again identified from the environment, along with genotypes VGIIb and VGIIc. CONCLUSIONS: The use of animal surveillance data to identify environmental niches of C. gattii should be considered to expand the understanding of this emerging pathogen. Understanding the ecology and how the environment and other factors might modify the existing niches is important for assessing risk and for designing measures to protect human and animal health.


Subject(s)
Cryptococcus gattii/isolation & purification , Plant Bark/microbiology , Soil Microbiology , Cryptococcus gattii/classification , Cryptococcus gattii/genetics , Genotype , Longitudinal Studies , Molecular Typing , Mycological Typing Techniques , Oregon
16.
J Womens Health (Larchmt) ; 33(5): 594-603, 2024 May.
Article in English | MEDLINE | ID: mdl-38608239

ABSTRACT

Objectives: Although invasive cervical cancer (ICC) rates have declined since the advent of screening, the annual age-adjusted ICC rate in the United States remains 7.5 per 100,000 women. Failure of recommended screening and management often precedes ICC diagnoses. The study aimed to evaluate characteristics of women with incident ICC, including potential barriers to accessing preventive care. Materials and Methods: We abstracted medical records for patients with ICC identified during 2008-2020 in five U.S. population-based surveillance sites covering 1.5 million women. We identified evidence of adverse social and medical conditions, including uninsured/underinsured, language barrier, substance use disorder, incarceration, serious mental illness, severe obesity, or pregnancy at diagnosis. We calculated descriptive frequencies and compared potential barriers by race/ethnicity, and among women with and without symptoms at diagnosis using chi-square tests. Results: Among 1,606 women with ICC (median age: 49 years; non-White: 47.4%; stage I: 54.7%), the majority (68.8%) presented with symptoms. Forty-six percent of women had at least one identified potential barrier; 15% had multiple barriers. The most common potential barriers among all women were being underinsured/uninsured (17.3%), and language (17.1%). Presence of any potential barrier was more frequent among non-White women and women with than without symptoms (p < 0.05). Conclusions: In this population-based descriptive study of women with ICC, we identified adverse circumstances that might have prevented women from seeking screening and treatment to prevent cancer. Interventions to increase appropriate cervical cancer screening and management are critical for reducing cervical cancer rates.


Subject(s)
Early Detection of Cancer , Health Services Accessibility , Uterine Cervical Neoplasms , Humans , Female , Uterine Cervical Neoplasms/prevention & control , Uterine Cervical Neoplasms/diagnosis , Middle Aged , United States/epidemiology , Adult , Early Detection of Cancer/statistics & numerical data , Health Services Accessibility/statistics & numerical data , Aged , Mass Screening/statistics & numerical data
18.
Clin Infect Dis ; 55(7): e58-60, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22715170

ABSTRACT

One human plague case was reported in Oregon in September 2010 and another in New Mexico in May 2011. Misidentification of Yersinia pestis by automated identification systems contributed to delayed diagnoses for both cases.


Subject(s)
Automation/methods , Bacteriological Techniques/methods , Diagnostic Errors , Plague/diagnosis , Yersinia pestis/isolation & purification , Adolescent , Delayed Diagnosis , Female , Humans , Male , Middle Aged , New Mexico , Oregon , Yersinia pestis/classification
19.
Front Immunol ; 13: 1075351, 2022.
Article in English | MEDLINE | ID: mdl-36569925

ABSTRACT

A young man with X-linked severe combined immunodeficiency developed a persistent vaccine-derived rubella virus (VDRV) infection, with the emergence of cutaneous granulomas more than fifteen years after receipt of two doses of measles-mumps-rubella (MMR) vaccine. Following nasopharyngeal swab (NP) collection, VDRV was detected by real-time polymerase chain reaction (RT-qPCR) and sequencing, and live, replication-competent VDRV was isolated in cell culture. To assess duration and intensity of viral shedding, sequential respiratory samples, one cerebrospinal fluid sample, and two urine samples were collected over 15 months, and VDRV RNA was detected in all samples by RT-qPCR. Live VDRV was cultured from nine of the eleven respiratory specimens and from one urine specimen. To our knowledge, this was the first reported instance of VDRV cultured from respiratory specimens or from urine. To assess potential transmission to close contacts, NP specimens and sera were collected from all household contacts, all of whom were immunocompetent and previously vaccinated with MMR. VDRV RNA was not detected in any NP swabs from the contacts, nor did serologic investigations suggest VDRV transmission to any contacts. This report highlights the need to understand the prevalence and duration of VDRV shedding in granuloma patients and to estimate the risk of VDRV transmission to immune and non-immune contacts.


Subject(s)
Severe Combined Immunodeficiency , X-Linked Combined Immunodeficiency Diseases , Male , Humans , Rubella virus , Measles-Mumps-Rubella Vaccine/adverse effects , Granuloma/genetics
20.
JFMS Open Rep ; 7(2): 20551169211053595, 2021.
Article in English | MEDLINE | ID: mdl-34777846

ABSTRACT

OBJECTIVES: The aim of this study was to determine the prevalence of internal parasites in feral and free-roaming owned cats in the region of Portland, Oregon, USA. METHODS: Fecal samples from asymptomatic cats were opportunistically collected from feral cats presented for surgical sterilization (n = 46), as well as free-roaming owned cats (n = 86) presented to primary care clinics. Fecal analysis was performed using the Baermann technique, centrifugal flotation, fluorescent auramine and fluorescent antibody for Giardia species. RESULTS: Lungworm infection was identified in 24.2% of owned cats and 17.2% of feral cats. At least 11 unique parasite species were identified in this study. Taenia species and Toxocara cati were identified in higher proportions in feral cats, whereas Giardia species were significantly higher in owned cats. CONCLUSIONS AND RELEVANCE: The prevalence of lungworm was higher than has been previously documented in other areas of the USA. In addition, feral cats were infected with a higher percentage of Toxocara species and Taenia but a significantly lower percentage of Giardia species.

SELECTION OF CITATIONS
SEARCH DETAIL